• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Self-regulation strategies linked to lower weight gain in young adults

byJames EnglandandAnees Daud
May 3, 2016
in Chronic Disease, Endocrinology, Public Health
Reading Time: 3 mins read
Parent/child feeding practices associated with weight status
Share on FacebookShare on Twitter

1. In a group of young-adults (18-35 year olds) with a BMI between 21 and 30, self-regulation strategies with small corrective changes in diet and activity, with or without an initial weight loss strategy, led to reduced long-term weight gain compared to a control group.

2. The study shows that meticulously following dietary and exercise plans can feasibly prevent weight gain in young-adults, and thus prevent long-term obesity-related adverse outcomes.

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Weight gain amongst young adults has significant adverse health risks. Strategies to prevent weight gain during young adulthood (ages 18-35) may be beneficial to improve lifelong outcomes in health. The Study of Novel Approaches to Weight Gain Prevention (SNAP) trial sought to evaluate the long-term effectiveness of strategies for self-regulation to prevent long-term weight gain in this population. The approaches evaluated a “small changes” strategy which included corrective changes to increase activity and decrease caloric intake for a deficit of 100 kcal/day if above target weight. The “large changes” strategy included the same interventions in addition to an initial 2.3-4.5 kg weight loss through intense dietary changes during the first 4 months of the study to buffer against weight gain. There was also a third, control group.

The results of the study showed that, at three years of follow up, showed that both the intervention groups effectively prevented against baseline weight gain compared to the control group. Compared to the control group, the intervention groups had lower incidence of obesity at the end of the study. The strength of the study was the study design, large sample size, and a long follow up period. The weaknesses of the study included predominance of females, high motivation of participants, and close follow-up afforded to the participants would not be feasible for the population at large.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

Relevant Reading: Self-Weighing Frequency Is Associated with Weight Gain Prevention over 2 Years Among Working Adults

In-Depth [randomized controlled trial]: This trial recruited 599 participants who were motivated to prevent weight gain. The participants were 22% male, 25% racial minority, aged 18-35 years and had starting BMI of 21.0 to 30.9. Individuals were randomized to the control arm, the small-changes arm, or the large-changes arm. The large-changes group had an initial 2.3-4.5 kg weight loss during the first 4 months. Both intervention groups underwent group meetings to learn about self-regulation of activity and caloric intake in response to daily weight measurements and were taught to make changes with regards to diet and exercise as a negative feedback if weight was above baseline.

The mean [SE] weight change at 3 years for the study groups were +0.26 [0.22] kg for the control group, -0.56 [0.22] kg for the small-changes group, and -2.37 [0.22] kg) for large-changes group. Differences between groups were significant: small-changes vs. control p = 0.02, large-changes vs. control p < 0.001, and large-changes vs. small-changes p < 0.001. There was a smaller proportion of individuals who gained more then 0.45 kg above baseline amongst the large-changes (23.6%) group compared to the small changes (32.5%, p = 0.02), and control group (40.8%, p < 0.001). The incidence of obesity was also less in the small-changes (7.9%, p = 0.002) and large-changes (8.6%, p = 0.02) groups compared to the control group (16.9%). There were no significant differences related to sex, age, ethnic background, or baseline weight.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: overweightweight loss
Previous Post

Triple therapy prolongs progression-free survival in Multiple Myeloma

Next Post

Decreased infant influenza disease burden linked to maternal immunization

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

July 9, 2026
Imaging and Intervention

Ring-augmented one-anastomosis gastric bypass may not improve weight loss compared to conventional one-anastomosis gastric bypass

June 10, 2026
Next Post
Decreased prevalence of HPV among vaccinated young females

Decreased infant influenza disease burden linked to maternal immunization

Unmet healthcare need in adolescence linked to poor adult outcomes

Outcomes remain poor in locally advanced pancreatic cancer

No significant improvement in older adult cognitive function with moderate physical activity

Calorie restriction improved quality of life in healthy non-obese adults

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.